Exchange Traded Concepts LLC lifted its stake in shares of Cognex Corporation (NASDAQ:CGNX - Free Report) by 10.2% during the second quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 505,657 shares of the scientific and technical instruments company's stock after purchasing an additional 46,669 shares during the quarter. Exchange Traded Concepts LLC owned about 0.30% of Cognex worth $16,039,000 at the end of the most recent reporting period.
A number of other hedge funds and other institutional investors have also modified their holdings of CGNX. Geneos Wealth Management Inc. grew its holdings in Cognex by 402.2% during the first quarter. Geneos Wealth Management Inc. now owns 919 shares of the scientific and technical instruments company's stock worth $27,000 after acquiring an additional 736 shares during the period. Farther Finance Advisors LLC grew its holdings in Cognex by 439.4% during the first quarter. Farther Finance Advisors LLC now owns 971 shares of the scientific and technical instruments company's stock worth $29,000 after acquiring an additional 791 shares during the period. GAMMA Investing LLC grew its holdings in Cognex by 155.3% during the first quarter. GAMMA Investing LLC now owns 1,062 shares of the scientific and technical instruments company's stock worth $32,000 after acquiring an additional 646 shares during the period. MassMutual Private Wealth & Trust FSB grew its holdings in Cognex by 231.9% during the second quarter. MassMutual Private Wealth & Trust FSB now owns 1,082 shares of the scientific and technical instruments company's stock worth $34,000 after acquiring an additional 756 shares during the period. Finally, UMB Bank n.a. grew its holdings in Cognex by 105.5% during the first quarter. UMB Bank n.a. now owns 1,280 shares of the scientific and technical instruments company's stock worth $38,000 after acquiring an additional 657 shares during the period. 88.12% of the stock is currently owned by institutional investors.
Cognex Trading Up 0.9%
Shares of CGNX traded up $0.41 during trading hours on Monday, hitting $46.89. 682,075 shares of the stock traded hands, compared to its average volume of 2,097,280. Cognex Corporation has a 1-year low of $22.67 and a 1-year high of $47.18. The firm has a market capitalization of $7.87 billion, a PE ratio of 66.08 and a beta of 1.50. The business has a fifty day moving average of $40.97 and a 200-day moving average of $33.49.
Cognex (NASDAQ:CGNX - Get Free Report) last released its quarterly earnings results on Wednesday, July 30th. The scientific and technical instruments company reported $0.25 EPS for the quarter, topping analysts' consensus estimates of $0.23 by $0.02. The company had revenue of $249.09 million for the quarter, compared to analyst estimates of $246.70 million. Cognex had a return on equity of 6.65% and a net margin of 13.13%.Cognex's revenue was up 4.2% compared to the same quarter last year. During the same quarter last year, the firm posted $0.23 earnings per share. Cognex has set its Q3 2025 guidance at 0.240-0.290 EPS. As a group, equities research analysts expect that Cognex Corporation will post 0.61 earnings per share for the current fiscal year.
Cognex Dividend Announcement
The firm also recently declared a quarterly dividend, which was paid on Thursday, August 28th. Shareholders of record on Thursday, August 14th were given a dividend of $0.08 per share. The ex-dividend date of this dividend was Thursday, August 14th. This represents a $0.32 annualized dividend and a yield of 0.7%. Cognex's payout ratio is 45.07%.
Analyst Ratings Changes
A number of research analysts recently issued reports on the company. Melius raised Cognex from a "hold" rating to a "buy" rating and set a $60.00 target price on the stock in a report on Thursday, July 10th. UBS Group boosted their target price on Cognex from $53.00 to $58.00 and gave the stock a "buy" rating in a report on Friday, August 1st. JPMorgan Chase & Co. began coverage on Cognex in a report on Monday, September 15th. They issued a "neutral" rating and a $45.00 target price for the company. KeyCorp raised Cognex from a "sector weight" rating to an "overweight" rating and set a $50.00 price target on the stock in a research report on Friday, August 1st. Finally, The Goldman Sachs Group lifted their price target on Cognex from $36.00 to $40.00 and gave the stock a "sell" rating in a research report on Tuesday, September 16th. One analyst has rated the stock with a Strong Buy rating, seven have assigned a Buy rating, seven have issued a Hold rating and one has issued a Sell rating to the stock. According to data from MarketBeat, the company currently has a consensus rating of "Moderate Buy" and a consensus price target of $43.07.
Check Out Our Latest Analysis on CGNX
Insider Activity at Cognex
In other news, EVP Sheila Marie Dipalma sold 2,002 shares of the firm's stock in a transaction dated Friday, September 5th. The stock was sold at an average price of $45.00, for a total value of $90,090.00. Following the completion of the transaction, the executive vice president owned 8,582 shares in the company, valued at $386,190. This trade represents a 18.92% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. 1.60% of the stock is currently owned by corporate insiders.
Cognex Profile
(
Free Report)
Cognex Corporation provides machine vision products that capture and analyze visual information to automate manufacturing and distribution tasks worldwide. Its machine vision products are used to automate the manufacturing and tracking of discrete items, including mobile phones, electric vehicle batteries, and e-commerce packages by locating, identifying, inspecting, and measuring them during the manufacturing or distribution process.
Further Reading

Before you consider Cognex, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Cognex wasn't on the list.
While Cognex currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.